The Follow the Money Team’s new report on Pfizer’s financials, based on Pfizer’s Q1 2023 reporting, offers many important insights: Pfizer reports that its mRNA COVID vaccine, Comirnaty®, manufacturing activities, performed on behalf of BioNTech, dropped 89% to only $5 million quarter-over-quarter. In its Q1 2023 report, Pfizer assumes no growth in market share for […]